Celldex Therapeutics, Inc. logo CLDX - Celldex Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 17
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $51.00 DETAILS
HIGH: $54.00
LOW: $48.00
MEDIAN: $51.00
CONSENSUS: $51.00
UPSIDE: 65.96%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Revenue
Revenue 1.5 7.0 6.9 2.4 4.7 7.4 3.6 9.5 12.7 6.8 5.5 3.6 4.1 11.2 9.3 46.8 15.2 7.5 5.1 4.9 3.1 6.9 4.6 6.7 3.3 0.8 1.5 2.2 1.2 1.1 4 7 9
Cost of Revenue 0 163.6 118.0 82.3 53.3 42.5 42.7 66.4 96.2 102.0 4.0 3.4 2.3 10.8 9.1 12.1 8.4 0 0 0 0 0 0 0.0 0.0 (0.7) (0.7) (0.4) (0.3) (0.1) 1.2 1.2 1.5
Gross Profit 1.5 (156.5) (111.1) (79.9) (48.7) (35.1) (39.1) (56.9) (83.4) (95.2) 1.5 0.2 1.8 0.4 0.1 34.7 6.8 7.5 5.1 4.9 3.1 6.9 4.6 6.7 3.3 1.5 2.2 2.6 1.5 1.2 2.8 5.8 7.5
Operating Expenses
R&D Expenses 245.1 163.6 118.0 82.3 56.8 40.5 42.7 66.4 96.2 102.7 100.2 104.4 67.4 47.4 32.4 27.6 26.2 26.3 18.5 18.1 14.1 13.9 10.0 14.7 21.6 10.8 7.9 5.7 5.3 6 8 8.7 0
SG&A Expenses 43.8 38.5 30.9 27.2 20.5 14.5 15.4 19.3 25.0 36.0 33.8 20.6 14.8 10.0 9.2 10.4 17.1 14.7 8.5 8.2 6.9 5.6 5.4 5.6 4.9 4.8 4.3 3.8 3.5 6.5 5.9 5.8 16
Other Expenses 0 (163.6) (105.5) (74.1) (54.7) (26.8) (42.2) 13.8 (83.1) (101.0) (99.2) (2.4) 1.0 1.1 1.9 3.1 0.3 0.4 1.0 1.0 1.0 1.0 1.0 0.8 1.4 1.3 2.0 1 0.4 0.5 0.7 0.8 0.9
Operating Expenses 288.9 38.5 43.4 35.3 22.6 28.2 15.9 99.5 38.1 37.7 34.9 122.6 83.2 58.5 43.6 41.2 43.6 41.5 28.0 27.3 22.0 20.4 16.4 21.1 27.9 16.9 14.1 10.5 9.2 13 14.6 15.3 16.9
Operating Income
Operating Income (287.4) (195.1) (154.5) (115.2) (71.2) (63.4) (55.0) (156.4) (121.5) (132.9) (129.5) (122.4) (81.4) (58.1) (43.4) (6.5) (32.9) (34.0) (22.9) (22.4) (18.9) (13.6) (11.7) (14.4) (24.6) (15.4) (11.9) (7.9) (7.7) (11.8) (11.8) (9.5) (9.4)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0.9 1.6 1.8 1.3 0.5 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 28.6 37.2 13.1 2.9 0.5 2.4 4.2 4.5 4.2 4.4 2.3 4.3 0 0.4 0 0 0 0 1.1 2.1 0.8 0.4 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA (255.4) (191.9) (139.0) (104.2) (66.1) (45.6) (49.7) (72.6) (104.0) (124.4) (125.5) (114.7) (77.7) (54.4) (38.8) 4.7 (33.1) (45.0) (19.1) (18.2) (16.5) (11.8) (10.2) (12.8) (22.3) (14.1) (10.0) (6.9) (7.3) (11.3) (11.1) (8.7) (8.5)
EBIT (258.8) (195.1) (142.0) (107.1) (69.1) (49.6) (54.5) (76.4) (109.3) (128.5) (129.5) (118.1) (80.6) (57.5) (43.0) (1.2) (36.6) (47.3) (21.8) (20.3) (18.1) (13.6) (11.7) (14.4) (24.6) (15.4) (11.9) (7.9) (7.7) (11.8) (11.8) (9.5) (9.4)
Income Before Tax (258.8) (157.9) (141.4) (112.3) (70.7) (60.9) (50.9) (151.9) (117.3) (128.5) (127.2) (118.1) (81.5) (59.1) (44.8) (2.5) (37.1) (47.5) (21.8) (20.3) (18.1) (13.2) (11.5) (13.8) (22.8) (22.0) (11.3) (7.9) (13.2) (10.8) (8.2) (11.6) (8.2)
Income Tax Expense 0 0 0 0 (0.2) (1.2) 0 (0.8) (24.3) 0 0 0 0 0 0 0 (0.5) 0 (0.1) 0.1 0 0 0 0 0 0 0 0 0 0 0 0 (2.8)
Net Income (258.8) (157.9) (141.4) (112.3) (70.5) (59.8) (50.9) (151.2) (93.0) (128.5) (127.2) (118.1) (81.5) (59.1) (44.8) (2.5) (36.5) (47.5) (21.6) (20.4) (18.1) (13.2) (12.7) (13.8) (22.8) (22.0) (11.3) (51.8) (13.1) (10.8) (8.3) (11.6) (7.8)
Per Share Data
EPS (Basic) -3.90 -2.45 -2.92 -2.40 -1.64 -2.02 -3.51 -14.48 -10.86 -18.99 -19.66 -19.81 -15.33 -15.37 -17.01 -1.19 -27.64 -50.12 -39.80 -49.41 -43.93 -32.57 -36.48 -41.17 -70.63 -75.43 -46.18 -281.04 -89.06 -89.61 -85.46 -122.55 -82.48
EPS (Diluted) -3.90 -2.45 -2.92 -2.40 -1.64 -2.02 -3.51 -14.48 -10.86 -18.99 -19.66 -19.81 -15.33 -15.37 -17.01 -1.19 -27.64 -50.12 -39.80 -49.41 -43.93 -32.57 -36.48 -41.17 -70.63 -75.43 -46.18 -281.04 -89.06 -89.61 -85.46 -122.55 -82.48
Shares Outstanding 66.5 64.4 48.4 46.9 42.9 29.6 14.5 10.4 8.6 6.8 6.5 6.0 5.3 3.8 2.6 2.1 1.3 0.9 0.5 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Current Assets
Cash & Cash Equivalents 28.9 28.4 34.8 29.4 39.1 43.8 11.2 24.3 40.3 42.5 57.0 44.3 31.7 20.3 25.1 42.7 50.2 13.6 8.9 6.4 12.6 12.3 7.6 28.3
Short-Term Investments 489.7 696.9 386.9 275.5 369.1 150.6 53.0 69.7 99.1 147.3 25.5 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 2.0 0.7 4.5 0.3 0.2 1.8 1.2 3.2 1.9 1.8 0.5 1.8 2.2 1.5 0.2 0.3 0.2 0.4 0 0 0.4 0.3 0.6 0.5
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.1 0 0 0 0 0.4 0.4 0.4
Other Current Assets 14.1 21.2 5.5 0 0 0 0 0 0 0 0 0.0 (0.0) 0 0 0 1.4 0.4 6.7 1 0.3 0.6 9.1 0.3
Total Current Assets 534.7 747.2 431.7 317.7 410.8 197.8 66.7 99.1 144.8 195.6 84.0 47.1 34.5 22.3 25.9 43.3 51.8 14.5 15.6 7.4 13.3 13.6 17.7 29.5
Non-Current Assets
Property, Plant & Equipment 7.8 8.2 6.6 7.7 6.5 7.3 7.5 6.1 10.4 13.2 11.5 13.6 4.2 0.9 1.1 1.0 1.0 1.3 1.1 0.4 0.5 1.2 1.1 1.8
Goodwill 0 0 0 0 0 0 0 0 91.0 91.0 9.0 0 1.0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 27.2 27.2 27.2 27.2 27.2 30.7 48.7 50.6 67.6 81.5 30.0 2.5 6.0 8.0 8.2 9.2 10.7 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 13.4 9.7 0.1 0.1 0.1 0.0 0.0 3.7 3.7 2.1 6.0 6.5 0.0 0.1 0.1 0 0 4.1 6 2 3.4 3.7 1.9 1.8
Total Non-Current Assets 48.3 45.2 33.9 35.0 33.8 38.0 56.2 56.7 170.9 187.8 56.4 22.7 11.3 9.0 9.4 10.1 11.8 5.4 7.1 2.4 3.9 4.9 3 3.6
Total Assets 583.0 792.3 465.6 352.7 444.7 235.8 122.9 155.8 315.6 383.4 140.4 69.8 45.8 31.3 35.2 53.5 63.6 19.9 22.7 9.8 17.2 18.5 20.7 33.1
Current Liabilities
Account Payables 1.2 3.3 3.5 3.3 1.2 1.0 1.2 1.1 1.7 1.7 1.4 5.1 1.8 0.5 0.8 1.1 0.9 0.6 0.4 0.2 0.3 0.7 0.8 0.5
Short-Term Debt 1.6 0 0 0 0 0 1.9 4.5 6.6 0 2.2 0.2 0.2 0 0 0 0.3 0.3 1 0.8 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 5.2 4.9 0.0 1.5 0.5 1.7 0 0 0 0 0 0 0 0
Other Current Liabilities 48.3 0.9 4.0 1.0 1.6 3.4 2.0 0 0 26.4 1.9 0.0 3.1 0 0 0 4.2 1.3 1.9 1.8 1.3 1.7 1.8 2.9
Total Current Liabilities 51.0 39.5 31.1 18.6 16.5 14.2 11.6 12.6 27.7 35.2 14.4 14.1 5.5 3.4 3.4 5.5 5.4 2.2 3.3 2.8 1.6 2.4 2.6 3.4
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 11.7 0.8 1.9 0 0 0 0 0.3 0.6 0.8 0 0.2 0.5 0.5
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 4.0 3.5 4.4 5.3 7.4 10.1 15.6 19.1 51.5 82.7 6.3 0.2 0 0 0.5 2.7 4.2 0 0 (0.1) 0 (0.1) 0 0.1
Total Non-Current Liabilities 4.8 5.8 5.3 7.9 8.7 12.3 17.3 19.1 51.5 82.7 52.2 37.6 1.9 1.9 0.5 2.7 4.2 0.3 0.6 0.7 0.3 0.1 0.5 0.6
Total Liabilities 55.8 45.3 36.5 26.5 25.2 26.5 28.9 31.7 79.3 117.9 66.6 51.7 7.4 3.4 3.9 8.2 9.6 2.5 3.9 3.5 1.6 2.5 3.1 4
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0 0 0 0 0 0
Retained Earnings (1,814.0) (1,555.2) (1,397.4) (1,255.9) (1,143.6) (1,073.1) (1,013.3) (962.4) (812.5) (719.5) (157.7) (121.1) (217.8) (204.6) (191.9) (178.1) (155.3) (133.3) (122) (70.2) (57.1) (46.3) (38.1) (26.5)
Accumulated Other Comprehensive Income 3.6 3.3 3.3 1.3 1.9 2.6 2.6 2.6 2.6 2.5 2.5 2.6 (1.5) (1.0) (4.4) (4.0) (4.1) (3.5) (2.9) (2.7) (2.5) (3.2) (3) (3.3)
Total Stockholders' Equity 527.2 747.0 429.2 326.2 419.5 209.4 94.0 124.1 236.4 265.4 73.8 18.1 38.4 27.9 31.3 45.3 53.9 17.4 18.8 6.3 15.6 16 17.6 29.1
Total Liabilities & Equity 583.0 792.3 465.6 352.7 444.7 235.8 122.9 155.8 315.6 383.4 140.4 69.8 45.8 31.3 35.2 53.5 63.6 19.9 22.7 9.8 17.2 18.5 20.7 33.1
Debt Metrics
Total Debt 2.3 3.8 2.5 4.0 3.0 3.5 3.7 4.5 6.6 0 13.8 1.0 0.2 0 0 0 0.3 0.6 1.6 1.6 0 0.2 0.5 0.5
Net Debt (26.5) (24.5) (32.3) (25.4) (36.1) (40.4) (7.6) (19.8) (33.7) (42.5) (43.2) (43.3) (29.6) (20.3) (25.1) (42.7) (49.9) (13.1) (7.3) (4.8) (12.6) (12.1) (7.1) (27.8)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Operating Activities
Net Income (258.8) (157.9) (141.4) (112.3) (70.5) (59.8) (50.9) (151.2) (93.0) (128.5) (18.1) (13.2) (12.7) (13.8) (22.8) (22.0) (11.3) (51.8) (13.1) (10.8) (8.3) (11.6) (7.8)
Depreciation & Amortization (2.5) 3.2 3.0 1.4 3.1 3.9 4.9 3.8 5.3 4.1 2.1 1.7 1.5 1.6 2.3 1.3 2.0 1 0.4 0.5 0.7 0.8 0.9
Stock-Based Compensation 36.2 34.2 23.9 0 9.0 3.9 4.6 8.1 12.3 15.3 538 328 115 0 0 0 0 0 0 0 0 0 0
Change in Working Capital 14.1 (21.6) 13.5 (3.9) (1.1) (0.3) (4.3) (15.4) (12.2) (6.6) 10.0 1.1 (1.8) (4.5) (0.4) 7.2 0.7 (2.8) (0.2) (0.8) (0.2) (0.9) 1.8
Other Non-Cash Items 0.0 (15.7) (6.2) 11.1 (1.1) 13.0 (1.3) 80.2 12.0 1.6 (0.0) 0.0 1.2 0 0.1 9.1 0.1 44.7 5.2 1.4 (0.1) 2.6 (0.4)
Operating Cash Flow (210.9) (157.8) (107.3) (103.7) (60.9) (40.4) (46.4) (75.2) (99.9) (113.0) (6.0) (10.3) (11.7) (16.7) (20.8) (4.4) (8.5) (8.9) (7.7) (9.7) (7.9) (9.1) (5.5)
Investing Activities
Capital Expenditure (2.7) (1.9) (1.8) (1.8) (1.2) (1.6) (0.7) (0.8) (1.8) (2.8) 0 0.0 (0.2) (0.6) (0.6) (0.2) (0.7) (0.3) (0.1) (0.6) (0.6) (0.8) (0.5)
Acquisitions 0 0 0 0.1 0.0 0.1 0.0 0.3 1.8 4.6 (2.2) (3.7) 0 0 0 (0.7) 0 0 0 0 0 0 0
Purchases of Investments (384.5) (789.9) (424.6) (189.0) (389.9) (220.3) (95.4) (171.2) (171.0) (175.7) 0 (2) 0 0 0 0 0 0 0 0 0 (1.2) 0
Sales/Maturities of Investments 596.3 501.7 320.6 280.7 174.9 123.6 113.2 201.5 219.2 242.8 0 4 0 0 0 0 4.9 4.5 0 0 8.5 14 13
Other Investing Activities 0 0 0 0 0 0 0 0 (1.8) 0 0.0 (0.0) (2) (0.3) (0.2) (0.1) (0.9) 3.4 1.6 0.4 (2) (0.4) (0.7)
Investing Cash Flow 209.1 (290.1) (105.8) 89.9 (216.2) (98.2) 17.1 29.8 46.5 68.9 (2.2) (1.7) (2.2) (0.8) (0.8) (1.0) 3.3 7.6 1.5 (0.2) 5.9 11.6 11.8
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 (0.2) 2.1 0 0 0 0 0 0 0 0 0 0 0.5
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 (0.1) (0.1) 0 0 0 0 0 0 (0.1) 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 9.2 2.2 0 2.5 0.4 0.0 0.4 0.3 0.5 0 0 (0.0) 0 0 0 0 0 0 0 0.2 0 0
Financing Cash Flow 2.4 441.4 218.5 4.1 272.4 171.2 16.3 29.4 51.3 14.5 (0.1) 25.5 9.1 (0.1) 14.1 42.0 10.0 3.7 0 10.2 6.7 0 17.7
Cash Position
Net Change in Cash 0.5 (6.5) 5.4 (9.7) (4.7) 32.6 (13.1) (16.0) (2.2) (29.6) (8.3) 13.5 (4.8) (17.6) (7.5) 36.6 4.7 2.5 (6.2) 0.3 4.7 2.5 24
Cash at Beginning 28.4 34.8 29.4 39.1 43.8 11.2 24.3 40.3 42.5 72.1 31.7 18.3 25.1 42.7 50.2 13.6 8.9 6.4 12.6 12.3 7.6 5.2 4.3
Cash at End 28.9 28.4 34.8 29.4 39.1 43.8 11.2 24.3 40.3 42.5 23.4 31.7 20.3 25.1 42.7 50.2 13.6 8.9 6.4 12.6 12.3 7.7 28.3
Free Cash Flow (213.7) (159.7) (109.1) (105.6) (62.2) (42.0) (47.1) (76.0) (101.7) (115.8) (6.0) (10.3) (11.9) (17.2) (21.4) (4.6) (9.2) (9.2) (7.8) (10.3) (8.5) (9.9) (6)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Income Statement
Revenue 1.5 7.0 6.9 2.4 4.7 7.4 3.6 9.5 12.7 6.8 5.5 3.6 4.1 11.2 9.3 46.8 15.2 7.5 5.1 4.9 3.1 6.9 4.6 6.7 3.3 0.8 1.5 2.2 1.2 1.1 4 7 9
Gross Profit 1.5 (156.5) (111.1) (79.9) (48.7) (35.1) (39.1) (56.9) (83.4) (95.2) 1.5 0.2 1.8 0.4 0.1 34.7 6.8 7.5 5.1 4.9 3.1 6.9 4.6 6.7 3.3 1.5 2.2 2.6 1.5 1.2 2.8 5.8 7.5
Operating Income (287.4) (195.1) (154.5) (115.2) (71.2) (63.4) (55.0) (156.4) (121.5) (132.9) (129.5) (122.4) (81.4) (58.1) (43.4) (6.5) (32.9) (34.0) (22.9) (22.4) (18.9) (13.6) (11.7) (14.4) (24.6) (15.4) (11.9) (7.9) (7.7) (11.8) (11.8) (9.5) (9.4)
Net Income (258.8) (157.9) (141.4) (112.3) (70.5) (59.8) (50.9) (151.2) (93.0) (128.5) (127.2) (118.1) (81.5) (59.1) (44.8) (2.5) (36.5) (47.5) (21.6) (20.4) (18.1) (13.2) (12.7) (13.8) (22.8) (22.0) (11.3) (51.8) (13.1) (10.8) (8.3) (11.6) (7.8)
EPS (Diluted) -3.90 -2.45 -2.92 -2.40 -1.64 -2.02 -3.51 -14.48 -10.86 -18.99 -19.66 -19.81 -15.33 -15.37 -17.01 -1.19 -27.64 -50.12 -39.80 -49.41 -43.93 -32.57 -36.48 -41.17 -70.63 -75.43 -46.18 -281.04 -89.06 -89.61 -85.46 -122.55 -82.48
Balance Sheet
Cash & Equivalents 28.9 28.4 34.8 29.4 39.1 43.8 11.2 24.3 40.3 42.5 57.0 44.3 31.7 20.3 25.1 42.7 50.2 13.6 8.9 6.4 12.6 12.3 7.6 28.3
Total Assets 583.0 792.3 465.6 352.7 444.7 235.8 122.9 155.8 315.6 383.4 140.4 69.8 45.8 31.3 35.2 53.5 63.6 19.9 22.7 9.8 17.2 18.5 20.7 33.1
Total Debt 2.3 3.8 2.5 4.0 3.0 3.5 3.7 4.5 6.6 0 13.8 1.0 0.2 0 0 0 0.3 0.6 1.6 1.6 0 0.2 0.5 0.5
Stockholders' Equity 527.2 747.0 429.2 326.2 419.5 209.4 94.0 124.1 236.4 265.4 73.8 18.1 38.4 27.9 31.3 45.3 53.9 17.4 18.8 6.3 15.6 16 17.6 29.1
Cash Flow
Operating Cash Flow (210.9) (157.8) (107.3) (103.7) (60.9) (40.4) (46.4) (75.2) (99.9) (113.0) (6.0) (10.3) (11.7) (16.7) (20.8) (4.4) (8.5) (8.9) (7.7) (9.7) (7.9) (9.1) (5.5)
Capital Expenditure (2.7) (1.9) (1.8) (1.8) (1.2) (1.6) (0.7) (0.8) (1.8) (2.8) 0 0.0 (0.2) (0.6) (0.6) (0.2) (0.7) (0.3) (0.1) (0.6) (0.6) (0.8) (0.5)
Free Cash Flow (213.7) (159.7) (109.1) (105.6) (62.2) (42.0) (47.1) (76.0) (101.7) (115.8) (6.0) (10.3) (11.9) (17.2) (21.4) (4.6) (9.2) (9.2) (7.8) (10.3) (8.5) (9.9) (6)